News ArchivesRead News
Gene therapy Beneficial in Parkinson’s Disease
Thursday October 26, 2006
19 Oct 2006(MedIndia.com) - The initial studies of human gene therapy for Parkinson’s disease has given the green signal to technique showing it to safe, and useful in reducing symptoms for patients, according to the reports of two groups of researchers.
In the neuroscience meetings held yesterday and last week the researchers reported that each of the 24 patients who received therapy in the two separate trials received some benefit and none had significant side effects.
Katie Hood, deputy chief executive officer of the Michael J. Fox Foundation for Parkinson’s Research said that gene therapy had a tarnished reputation because of problems encountered in trials against other diseases.
In 1999 the Food and Drug Administration temporarily halted gene therapy trials after an 18-year-old who was treated for a mild genetic disorder died after a violent reaction to the procedure. in 2005 trials were again brought to a standstill after three French children who was treated for inherited immuno- deficiency disease developed leukemia and one of them died.
Hood said, ``It’s very encouraging that two companies were able to show benefits with no significant adverse effects. Safety is obviously the first hurdle."
Patients have been cautioned however against placing too much hope in the findings because Parkinson’s studies have been infamous for showing placebo effects. Researchers say that only when the techniques are tested in controlled trials, which are now in the planning stages, can they determine whether the benefits are real, and long-lasting or not.
Recent NewsSep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show
Aug 14 - 16 Tips to Increase Your Mobility Confidence While Living With Parkinson’s Disease
Aug 10 - Boxers are fighting back against Parkinson’s
Aug 9 - Parkinson’s Experiment to Be Aboard Next Flight to International Space Station
Aug 9 - Parkinson’s Disease and Sleeping with the Enemy
Aug 7 - The Importance of Oral Health in Parkinson’s Disease
Aug 7 - Researchers Gain Better Insight Into Alpha-Synuclein’s Role in Parkinson’s Disease
Jul 31 - New Digital Cognitive Assessment Tool Receives Positive FDA Review
Jul 20 - Parkinson’s DREAM Challenge Uses Mobile Sensor Data to Monitor Health Based on Movement